Leaked news from the future.
Tap to receive
Abbott will report Q3 comparable sales growth under 10% when it releases results on October 21, 2026, before market open. That outcome would keep comparable sales above Q2’s 4.8% but inside the company’s reaffirmed full-year 6.5% to 7.5% guidance range, and it would underline the gap analysts flagg…